| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/17/2008 | EP1447400B1 Bicyclic compound |
| 09/17/2008 | EP1446383B1 Monohydroxycarbamazepine for use in the preparation of a medicament for the treatment of affective and attention disorder and neuropathic pain |
| 09/17/2008 | EP1409477B1 Piperidine derivatives as nmda receptor antagonists |
| 09/17/2008 | EP1408940B1 Pharmaceutical composition comprising deramciclane for the treatment of the decline and/or damage of cognitive functions |
| 09/17/2008 | EP1392639B1 Pyruvate derivatives |
| 09/17/2008 | EP1379557B1 Use of cd25 binding molecules in steroid-resistant patients |
| 09/17/2008 | EP1372551B1 Facially amphiphilic polymers as anti-infective agents |
| 09/17/2008 | EP1307450B1 2-(4-Pyridyl)amino-6-dialkoxyphenyl-pyrido(2,3-d)pyrimidin-7-ones |
| 09/17/2008 | EP1305282B1 Pleuromutilin derivatives having antibacterial activity |
| 09/17/2008 | EP1254122B1 Novel 3-substituted 1,2,4-benzotriazines, a method for their production and the use thereof |
| 09/17/2008 | EP1233670B1 Nitric oxide donors for inducing neurogenesis |
| 09/17/2008 | EP1202748B1 Polycation-based bioconjugates |
| 09/17/2008 | EP1202736B1 Nicotine in therapeutic angiogenesis and vasculogenesis |
| 09/17/2008 | EP1009440B1 Method for inhibiting immunostimulatory dna associated responses |
| 09/17/2008 | EP0712303B2 Skin patches comprising testosterone and optionally estrogen |
| 09/17/2008 | CN101268101A Anti-CTLA-4 antibody and CpG-motif-containing synthetic oligodeoxynucleotide combination therapy for cancer treatment |
| 09/17/2008 | CN101268085A Boron compounds useful in BNCT |
| 09/17/2008 | CN101268084A Caspase inhibitor prodrugs |
| 09/17/2008 | CN101268082A Thienopyrimidine and thienopyridine derivatives as FLT-3 kinase inhibitors |
| 09/17/2008 | CN101268079A Pyridazinone derivatives used for the treatment of pain |
| 09/17/2008 | CN101268078A Pyrazolo[3,4-b]pyridine compound, and its use as a pde4 inhibitor |
| 09/17/2008 | CN101268077A Tricyclic benzimidazoles and their use as metabotropic glutamate receptor modulators |
| 09/17/2008 | CN101268075A Substituted tetrahydro-1H-pyrido[4,3-B]indoles as serotonin receptors agonists and antagonists |
| 09/17/2008 | CN101268074A 5-amino-4-hydroxy-7- (imidazo [1,2-A] pyridin-6- ylmethyl)-8-methyl-nonamide derivatives and related compounds as renin inhibitors for the treatment of hypertension |
| 09/17/2008 | CN101268073A Heterocyclic compound, and production process and use thereof |
| 09/17/2008 | CN101268071A Novel 1-aza bicycloalkyl derivatives for the treatment of psychotic and neurodegenerative disorders |
| 09/17/2008 | CN101268070A Novel sulphonylpyrroles as inhibitors of HDAC novel sulphonylpyrroles |
| 09/17/2008 | CN101268069A Phenyl- and pyridyl-i,2,4 -oxadiazolone derivatives with phenyl group, processes for their preparation and their use as pharmaceuticals |
| 09/17/2008 | CN101268068A Beta-lactamyl phenylalanine, cysteine, and serine vasopressin antagonists |
| 09/17/2008 | CN101268067A Indol-3-yl-carbonyl-piperidin-benzoimidazole derivatives as V1A receptor antagonists |
| 09/17/2008 | CN101268065A Process for preparing an angiotensin II receptor antagonist |
| 09/17/2008 | CN101268063A Thiophene derivatives for the treatment of diabetes |
| 09/17/2008 | CN101268062A 2-hydroxy-propionic acid derivatives and 3-hydroxy-benzofuran-2-one derivatives with affinity for the GABA-B-receptor |
| 09/17/2008 | CN101268058A 4-phenyl-6-substituted-pyrimidine-2-carbonitrile derivatives |
| 09/17/2008 | CN101268054A Substituted 4-phenyltetrahydroisoquinolines, process for their preparation, pharmaceutical compositions and therapeutic use |
| 09/17/2008 | CN101268053A Alkylnitrile quinolines, as NK-3 receptor ligands |
| 09/17/2008 | CN101268052A N-oxo-heterocycle and N-oxo-alkyl quinoline-4-carboxamides as NK-3 receptor ligands |
| 09/17/2008 | CN101268051A Isotopically substituted proton pump inhibitors |
| 09/17/2008 | CN101268050A Isotopically substituted pantoprazole |
| 09/17/2008 | CN101268049A Novel piperidine derivatives |
| 09/17/2008 | CN101268048A Carbazole derivatives |
| 09/17/2008 | CN101268047A Crystalline and amorphous sodium atorvastatin |
| 09/17/2008 | CN101268046A Carboxamide derivatives as muscarinic receptor antagonists |
| 09/17/2008 | CN101268043A Amino-alkyl-amide derivatives as CCR3 receptor ligands |
| 09/17/2008 | CN101268042A Styrylsulfonamides, their manufacture and use as pharmaceutical agents |
| 09/17/2008 | CN101268041A Sulphonamide derivatives |
| 09/17/2008 | CN101268038A Amino-alkyl-amide derivatives as CCR3 receptor ligands |
| 09/17/2008 | CN101267859A A pharmaceutical composition useful for the treatment of prostate cancer |
| 09/17/2008 | CN101267849A Porous coating loaded with a liquid or a solid substance |
| 09/17/2008 | CN101267837A Compositions for treatment of systemic mastocytosis |
| 09/17/2008 | CN101267828A Compositions and methods for the co-delivery of anti-cancer drugs, anti-angiogenic drugs, and a polysaccharide |
| 09/17/2008 | CN101267827A Oral contraception with trimegestone |
| 09/17/2008 | CN101267826A Use of C3-C10 17alfa-esters of 9,11-dehydrocortexolone as anti-gonadotrophic agents |
| 09/17/2008 | CN101267825A Benzodiazepine derivatives for treating hepatitis C infection |
| 09/17/2008 | CN101267824A Dosage forms and methods of treatment using a tyrosine kinase inhibitor |
| 09/17/2008 | CN101267823A Combination drug containing probucol and a tetrazolylalkoxy-dihydrocarbostyril derivative with superoxide supressant effects |
| 09/17/2008 | CN101267822A Use of inhibitors of the Na+/H+ exchanger, subtype 5(NHE5), to improve memory retention |
| 09/17/2008 | CN101267821A Synergistic modulation of FLT3 kinase using a FLT3 inhibitor and a farnesyl transferase inhibitor |
| 09/17/2008 | CN101267820A Novel azabicyclo[3.2.1]oct-2-ene derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 09/17/2008 | CN101267819A Combination of a long-acting hypnotic agent and a short-acting hypnotic agent and therapeutic use thereof |
| 09/17/2008 | CN101267818A Uses of amino acid and amino acid supplements thereof |
| 09/17/2008 | CN101267817A Amino acid and its uses |
| 09/17/2008 | CN101267816A Methods of treatment using hydroquinone ansamycins |
| 09/17/2008 | CN101267815A Metal-beta-lactamase inhibitor |
| 09/17/2008 | CN101267814A Association of beta3 receptor agonist and monoamine reuptake inhibitors, pharmaceutical composition and therapeutic use thereof |
| 09/17/2008 | CN101267813A Substituted propanamide derivative and pharmaceutical composition containing the same |
| 09/17/2008 | CN101267812A Hydrazone agents to treat cutaneous lesions |
| 09/17/2008 | CN101267811A Novel multi-cyclic compounds and their use |
| 09/17/2008 | CN101267810A Capsule formulation of pirfenidone and pharmaceutically acceptable excipients |
| 09/17/2008 | CN101267809A Sugar coatings and methods therefor |
| 09/17/2008 | CN101267808A 新型制剂 The new formulation |
| 09/17/2008 | CN101267807A Composition comprising a nsaid and paracetamol |
| 09/17/2008 | CN101267806A Sustained release of antifectives |
| 09/17/2008 | CN101267805A Systems and methods for manufacturing liposomes |
| 09/17/2008 | CN101267746A Liquid formulation based on a guanidinoacetic acid component |
| 09/17/2008 | CN101265304A Bionic chitosan derivatives, preparation method thereof and lipoid plastid preparation containing the same |
| 09/17/2008 | CN101265285A Immunostimulatory nucleic acid molecules |
| 09/17/2008 | CN101265281A Method for preparing dithioamnoformic acid modifying glucose chelating agent |
| 09/17/2008 | CN101265275A Diethyl 4-{6-[5-(2-chloro-6-methylanilinoformacyl)-thiazolyl-2-amino]-2-methylpyrimidin-4}-piperazin-1-phosphate |
| 09/17/2008 | CN101265274A Pyrimidinthiazolamine derivatives, and preparation method, medicament composition and use thereof |
| 09/17/2008 | CN101265267A Method for preparing cefozopran hydrochloride, cefozopran hydrochloride powder injection and preparation method thereof |
| 09/17/2008 | CN101265266A Sinomenine derivative, preparation method and application thereof |
| 09/17/2008 | CN101265265A Method for producing high-purity azlocillin sodium and powder injection thereof |
| 09/17/2008 | CN101265264A Method for producing high-purity mezlocillin sodium and powder injection thereof |
| 09/17/2008 | CN101265263A Method for producing piperacillin sodium tazobactam sodium compound injection |
| 09/17/2008 | CN101265262A New oxabispidine compounds useful in the treatment of cardiac arrhythmias |
| 09/17/2008 | CN101265259A Novel IDO inhibitor and its usage method |
| 09/17/2008 | CN101265254A Novel IDO inhibitor and its usage method |
| 09/17/2008 | CN101265251A Method for extracting naringenin from Chinese medicament chinaroot greenbrier and application thereof |
| 09/17/2008 | CN101265250A Substituted flavonoids and preparation method, application and pharmaceutical composition thereof |
| 09/17/2008 | CN101265249A 4-position carbonyl nitrogen-containing derivative of 6-methoxy-4',7-dihydroxyisoflavone and medical use thereof |
| 09/17/2008 | CN101265248A Cembrene lactone type diterpenoid lobophilides A and B, and preparation method and use thereof |
| 09/17/2008 | CN101265239A Amorphous form of valsartan |
| 09/17/2008 | CN101265237A Diaryltriazine derivatives and preparation method thereof |
| 09/17/2008 | CN101265233A Radiation and chemotherapy sensitizing agent-glucosamine glycididazole and preparation method thereof |
| 09/17/2008 | CN101265226A Compounds and methods for delivery of prostacyclin analogs |
| 09/17/2008 | CN101265214A Methylophtocillin ester and its salts, and preparation method, application and pharmaceutical composition thereof |
| 09/17/2008 | CN101265212A Antineoplastic alkanna tinctoria ketoximes derivatives |
| 09/17/2008 | CN101265199A Method for the preparation of escitalopram |
| 09/17/2008 | CN101265178A Amino acid salt of (S)-ibuprofen and medicinal composition thereof |